Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
04/2010
04/15/2010US20100093974 Linkers and Co-Coupling Agents for Optimization of Oligonucleotide Synthesis and Purification on Solid Supports
04/15/2010US20100093836 Compounds and methods for modulating protein expression
04/15/2010US20100093656 Phosphate modified nucleosides useful as substrates for polymerases and as antiviral agents
04/15/2010US20100093609 Prodrugs of triciribine and triciribine phosphate
04/15/2010US20100093068 System and methods for nucleic acid sequencing of single molecules by polymerase synthesis
04/15/2010US20100092971 Compound having structure derived from mononucleoside or mononucleotide, nucleic acid, labeling substance, and method and kit for detection of nucleic acid
04/15/2010US20100092957 Compositions and methods for nucleotide sequencing
04/14/2010EP2173760A2 Carbocyclic bicyclic nucleic acid analogs
04/14/2010EP2173759A1 Oligosialic acid derivatives, methods of manufacture, and immunological uses
04/14/2010EP2173352A2 Inhibitors of akt/pkb with anti-tumor activity
04/13/2010US7696345 Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
04/13/2010US7696181 Partial and full agonists of A1 adenosine receptors
04/13/2010US7696164 Substantially pure glycopeptide antibiotics AC-98-1 ; AC-98-2; AC-98-3; AC-98-4 and AC-98-5
04/13/2010CA2399208C Nucleoside analogs with carboxamidine modified monocyclic base
04/08/2010WO2010038874A1 Anti-xdr-tb agent, anti-mdr-tb agent, and combined anti-tuberculous agent
04/08/2010WO2010037179A1 Anionic conjugates of glycosylated bacterial metabolite
04/08/2010US20100087637 Synthesis of Decitabine
04/08/2010US20100087636 Process for the synthesis of ib-meca
04/08/2010US20100087634 Fluorous Oligonucleotide Reagents and Affinity Purification of Oligonucleotides
04/08/2010US20100087387 Five- and six-membered conformationally locked 2',4'-carbocyclic ribo-thymidines for the treatment of infections and cancer
04/08/2010CA2739505A1 Anti-xdr-tb agent, anti-mdr-tb agent, and combined anti-tuberculosis agent
04/07/2010EP2170920A1 Stable salts of s-adenosylmethionine and process for the preparation thereof
04/07/2010EP2170919A2 Improved process for the production of nucleotide sugars
04/07/2010EP2170918A2 Derivatives of nucleoside-5'-o-hypophosphates and their mono- and dithiohypophosphate analogues and the process for the manufacture thereof
04/07/2010EP2170917A2 N-substituted-aminomethylene bridged bicyclic nucleic acid analogs
04/07/2010EP2170350A2 Substituted imidazoheterocycles
04/07/2010EP2170057A1 5'-substituted adenosynes, preparation thereof and use as inhibitors of s-adenosylmethionine decarboxylase
04/06/2010US7691827 Amide prodrug of gemcitabine, compositions and use thereof
04/06/2010US7691825 Adenosine A2B receptor agonists
04/06/2010US7691820 Administering a 1-(4-thio-beta-D-arabinofuranosyl)- cytosine or 5- or 6-aza compound for inhibiting replication of DNA, immunomodulation and treatment of autoimmune diseases; also claimed is 1-(4-thio- beta -D-arabinofuranosyl)-5-fluorocytosine.
04/06/2010US7691635 Such as heat resistant diazomethyl compounds; kits for solid phase nucleic acid synthesis
04/01/2010WO2010036698A1 Substituted alpha-l-bicyclic nucleosides
04/01/2010WO2010036696A1 Cyclohexenyl nucleic acid analogs
04/01/2010WO2010036213A1 3-deazaneplanocin derivatives
04/01/2010WO2009037592A3 Triazole-based aminoglycoside-peptide conjugates and methods of use
04/01/2010US20100081810 C-Pyrazole A2A Receptor Agonists
04/01/2010US20100081802 Synthesis of Phosphitylated Compounds Using a Quaternary Heterocyclic Activator
04/01/2010US20100081628 Nucleoside cyclicphosphates
04/01/2010US20100081627 Polymeric nucleoside prodrugs
04/01/2010US20100080824 A formulation comprising a cell culture extract of an isolated virus is identified to be morphologically and phylogenetically similar to the known member of coronaviruses; kits comprising containers containing the formulation used in medical diagnosis, as vaccines and antibodies
03/2010
03/31/2010EP2168973A1 Nucleic acid ligand complexes
03/31/2010EP2167523A2 Synthesis and use of anti-reverse phosphorothioate analogs of the messenger rna cap
03/31/2010EP2167522A2 Triazole-based aminoglycoside-peptide conjugates and methods of use
03/31/2010EP1758596B1 Purine derivatives as adenosine a1 receptor agonists and methods of use thereof
03/31/2010CN101687899A Therapeutic agent for ulcerative colitis comprising mizoribine
03/31/2010CN101687898A maize polymorphisms and methods of genotyping
03/31/2010CN101686989A substituted imidazoheterocycles
03/31/2010CN101684136A Method for preparing oligonucleotides
03/31/2010CN101684135A Methyl furan nucleoside compound, preparing method and application thereof
03/31/2010CN101684134A Synthetic process of 5-[3-(biotin acylamino hexanoyl)-amido]-propenyl-2'-deoxycholic-5'-uridine triphosphate lithium salt
03/30/2010US7687618 Method of manufacturing labelled oligonucleotide conjugates
03/30/2010US7687480 Phosphonate compounds
03/30/2010US7687470 Avermectin and avermectin monosaccharide substituted in the 4″- and 4″ position respectively
03/30/2010US7687236 Fluorescent nucleobase conjugates having anionic linkers
03/30/2010CA2550299C Process for fluorocytidine derivatives
03/30/2010CA2403326C Methods of protein detection utilizing cleavable identifying tags
03/25/2010WO2010031954A1 Short synthetic pathway for 1,6:2,3-dianhydro-beta-d-mannopyranose
03/25/2010WO2010031953A1 Method for preparing 1,6:2,3-dianhydro-beta-d-mannopyranose
03/25/2010WO2009098404A8 Method for preparing nanoparticles based on functional amphiphilic molecules or macromolecules, and the use thereof
03/25/2010US20100075917 Thionucleosides and pharmaceutical applications
03/25/2010US20100074850 Flavour Modulating Derivative of a Carboxylic Acid and a Purine, Pyrimidine, Nucleoside, or Nucleotide
03/25/2010CA2735781A1 Short synthetic pathway for 1,6:2,3-dianhydro-beta-d-mannopyranose
03/25/2010CA2735537A1 Method for preparing 1,6:2,3-dianhydro-.beta.-d-mannopyranose
03/24/2010EP2166016A1 Phosphoramidate Derivatives of Nucleosides
03/24/2010EP2164856A1 Processes related to making capecitabine
03/24/2010EP1492805B1 System for tracing animal products
03/24/2010CN101679472A Compounds for preventing or treating viral infections and methods of use thereof
03/24/2010CN101676295A Method for purifying and separating 2'-deoxidized-2',2'-difluoro nucleotide
03/23/2010US7683164 Nucleic acid derivatives
03/23/2010CA2375374C Induction of pharmacological stress with adenosine receptor agonists
03/18/2010WO2010029574A2 An improved process for the preparation of gemcitabine and its intermediates using novel protecting groups and ion exchange resins
03/18/2010WO2010028781A1 8- and 6,8-substituted-2'-deoxyguanosines and uses thereof
03/18/2010US20100069625 Process for preparing of 2'-deoxy-2'2'-difluorocytidine
03/18/2010US20100069624 Nucleic Acid Mediated Electron Transfer
03/18/2010US20100069319 Mercaptopurine derivatives and uses thereof
03/18/2010US20100069258 Hydrophilic Labels for Biomolecules
03/18/2010US20100068786 Methods and compositions for reversing p-glycoprotein medicated drug resistance
03/18/2010US20100068179 Phosphohalohydrins, Process For The Production Thereof And Use Thereof
03/17/2010EP2163652A1 Preparing crude biological extracts using protease, suitable for preparing cDNA
03/17/2010EP2162458A1 Protein kinase-binding nucleosides and associated methods
03/16/2010US7678894 comprise a label attached to the nitrogenous base portion of the analog via a cleavable linker at the N4, O4, N6 or O6 position; reversible inhibitors or blockers that allow the incorporation of only one nucleotide per addition cycle in a template-dependent sequencing-by-synthesis reaction
03/16/2010US7678773 Salts of avermectins substituted in the 4″-position and having pesticidal properties
03/16/2010CA2360069C Protecting groups for carbohydrate synthesis
03/11/2010WO2010027005A1 Substituted amine derivative and medicinal composition comprising same as the active ingredient
03/11/2010WO2010026490A1 Design, synthesis and use of synthetic nucleotides comprising charge mass tags
03/11/2010WO2010026439A1 Enantiomeric resolution of 2,4-disubstituted 1,3-oxathiolane nucleosides
03/11/2010WO2010026153A1 Nucleoside derivatives as inhibitors of viral polymerases
03/11/2010WO2010025584A1 Dna molecule for expressing haripin rna, the constructing method and the use thereof
03/11/2010WO2010025566A1 Rna monomers containing o-acetal levulinyl ester groups and their use in rna microarrays
03/11/2010WO2009142822A3 2-f modified rna interference agents
03/11/2010US20100062996 Dioxolane derivates for the treatment of cancer
03/11/2010US20100062995 Transition state structure of human 5'methylthioadenosine phosphorylase
03/11/2010US20100062994 Adenosine Receptor Antagonists
03/11/2010US20100062992 Salts of 5-Azacytidine
03/11/2010CA2772434A1 Rna monomers containing o-acetal levulinyl ester groups and their use in rna microarrays
03/11/2010CA2736163A1 Enantiomeric resolution of 2,4-disubstituted 1,3-oxathiolane nucleosides
03/11/2010CA2735783A1 Nucleoside derivatives as inhibitors of viral polymerases
03/11/2010CA2735251A1 Rna synthesis - phosphoramidites for synthetic rna in the reverse direction, and application in convenient introduction of ligands, chromophores and modifications of synthetic rna at the 3' - end
03/10/2010EP2160474A1 Nucleotide analogs
03/10/2010EP2160397A1 A novel and highly stereoselective process for preparing gemcitabine and intermediates thereof
1 ... 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 ... 201